K893453

Substantially Equivalent

GLYCABEN

Applicant: Exocell, Inc.
Product code: LCP
Advisory panel: Hematology
Date received: 1989-05-03
Decision date: 1989-10-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Philadelphia, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.